First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commercial launch ...
GVOKE is the first premixed, prefilled, premeasured liquid glucagon offering ease of use for pediatric and adult patients with diabetes ages 2 years and above or caregivers to rapidly treat severe ...
Diabetes patients have long relied on complex glucagon kits to treat hypoglycemia. Late last summer, Xeris Pharmaceuticals aimed to change that with the first FDA-approved prefilled syringe. Now, its ...
Gvoke (glucagon) can cause side effects that range from mild to serious. More common side effects include nausea and vomiting. If side effects from Gvoke become difficult to tolerate, talk with your ...
Xeris Pharmaceuticals, a specialty pharmaceutical company has received the Food and Drug Administration’s blessing for Gvoke (glucagon) injection, a ready-to-use, room-temperature stable liquid ...
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use ...
"Abel may grow into it. But he's no Warren Buffett." Empty seats and diminished crowds were noticeable throughout Berkshire's annual shareholder weekend in Omaha. Reuters, the news and media division ...
SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc. ® is pleased to announce the commercial launch and availability of Gvoke VialDx™ (glucagon injection). Gvoke VialDx (glucagon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results